JOHNSON & JOHNSON – Group report and key figures

WHAT IS THE GROUPS' FINANCIAL SITUATION ?

The financial indicators presented in this report include: consolidated revenue, consolidated EBIT and EBIT ratio, consolidated net profit and net profit rate, R&D expenditure and ratio, sales by segment and by region, profitability, liquidity and solvency ratios, free cash flow and capital expenditure.

WHAT ARE THE GROUP'S STRATEGIC PRIORITIES ?

Major portfolio strengthening in Innovative Medecine

Raise competitiveness of MedTech portfolio through strategic M&A

Complete full exit from Consumer Health market

WHAT ARE THE GROUP'S STRENGTHS AND WEAKNESSES ?

Through a SWOT analysis, this report also provides an overview of the group's strengths (strong innovation pipeline and a leading global R&D spender, etc.) and weaknesses (the US market accounts for more than half of turnover, etc.).

1. Overview

Presentation

Segments

SWOT

2. Corporate Strategies and Recent Events

3. Financial Indicators

4. Statistical Appendix

5. Glossary